BRAIN: Building Reliable Advances and Innovation in Neurotechnologies NSF Initiative Launches March 10 at Arizona State University

The BRAIN Center will develop safe, effective and affordable personalized neurotechnologies for diagnostics, restoration, enhancement, and rehabilitation of sensory, motor, affective and cognitive functions. This mission will be pursued by supporting innovative interdisciplinary research across the multiple dimensions of brain function and behavior with the ultimate goal of improving quality of life.
Continue reading

Barrow neurosurgeon helps pave way for deep brain stimulation and Alzheimer’s

Neurosurgeons at Barrow Neurological Institute in Phoenix are involved with testing the viability of deep brain stimulation (DBS) to treat Alzheimer’s disease, a disorder that currently has few treatment options. Results from the Phase 2 study, reported in the Journal of Neurosurgery on
Dec. 18, 2015, demonstrated the safety of DBS in Alzheimer’s patients.Continue reading

Simpler technique yields antibodies to a range of infectious agents

Researchers at Arizona State University’s Biodesign Institute explores an innovative means of investigating membrane proteins produced by a pair of highly pathogenic organisms. The research team showed that DNA-based genetic immunization, using a device known as a gene gun, could successfully express membrane proteins in mice and induce the animals to produce a range of critical antibodies to bacterial and viral targets.

Continue reading

CANCER MOONSHOT 2020 ANNOUNCES THE FORMATION OF A NATIONAL PEDIATRICS CONSORTIUM, A MAJOR MILESTONE IN THE WAR ON CANCER IN CHILDREN

Leading national children’s hospitals, pediatric cancer organizations and academic centers unite with Cancer MoonShot 2020 to accelerate bringing the next-generation standard of cancer care and immunotherapy to children with cancer.  The Cancer MoonShot 2020 Pediatrics Consortium include 10 founding members spanning major cities across the nation who will participate in a national data sharing infrastructure to accelerate clinical development of next-generation immunotherapyContinue reading